Literature DB >> 10407053

Cognitive deficits in a genetic mouse model of the most common biochemical cause of human mental retardation.

L Zagreda1, J Goodman, D P Druin, D McDonald, A Diamond.   

Abstract

Phenylalanine hydroxylase (Pah)-deficient "PKU mice" have a mutation in the Pah gene that causes phenylketonuria (PKU) in humans. PKU produces cognitive deficits in humans if it is untreated. We report here the first evidence that the genetic mouse model of PKU (Pah(enu2)) also produces cognitive impairments. PKU mice were impaired on both odor discrimination reversal and latent learning compared with heterozygote littermates and with wild-type mice of the same BTBR strain. A small container of cinnamon-scented sand was presented on the right or left, and nutmeg-scented sand was presented on the other side; left-right location varied over trials. Digging in sand of the correct scent was rewarded by finding phenylalanine-free chocolate. To prevent scent cuing, new containers were used on every trial, and both containers always contained chocolate. Digging in the incorrect choice was stopped before the chocolate was uncovered. Once criterion was reached, the other scent was rewarded. PKU mice were impaired on reversals 2, 3, and 4. They were also impaired in latent learning. On day 1, half the mice were allowed to explore a maze and discover the location of water. On day 2, all mice were water-deprived and were placed in the maze. Whereas pre-exposed wild-type and heterozygous mice showed evidence that they remembered the location of the water and hence could find the water faster on day 2, pre-exposed PKU mice showed no significant benefit from their pre-exposure on day 1.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10407053      PMCID: PMC6783085     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  10 in total

1.  Reversal and nonreversal shifts in discrimination learning in retardates.

Authors:  B HOUSE; D ZEAMAN
Journal:  J Exp Psychol       Date:  1962-05

2.  Tight linkage between a splicing mutation and a specific DNA haplotype in phenylketonuria.

Authors:  A G DiLella; J Marvit; A S Lidsky; F Güttler; S L Woo
Journal:  Nature       Date:  1986 Aug 28-Sep 3       Impact factor: 49.962

3.  Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium.

Authors: 
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

4.  Preliminary report on the effects of diet discontinuation in PKU.

Authors:  R Koch; C G Azen; E G Friedman; M L Williamson
Journal:  J Pediatr       Date:  1982-06       Impact factor: 4.406

5.  Regional mapping of the phenylalanine hydroxylase gene and the phenylketonuria locus in the human genome.

Authors:  A S Lidsky; M L Law; H G Morse; F T Kao; M Rabin; F H Ruddle; S L Woo
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

6.  Conservation of hippocampal memory function in rats and humans.

Authors:  M Bunsey; H Eichenbaum
Journal:  Nature       Date:  1996-01-18       Impact factor: 49.962

7.  Neonatal monoaminergic depletion in mice (Mus musculus) improves performance of a novel odor discrimination task.

Authors:  J Berger-Sweeney; M Libbey; J Arters; M Junagadhwalla; C F Hohmann
Journal:  Behav Neurosci       Date:  1998-12       Impact factor: 1.912

8.  Mouse models of human phenylketonuria.

Authors:  A Shedlovsky; J D McDonald; D Symula; W F Dove
Journal:  Genetics       Date:  1993-08       Impact factor: 4.562

9.  Pahhph-5: a mouse mutant deficient in phenylalanine hydroxylase.

Authors:  J D McDonald; V C Bode; W F Dove; A Shedlovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

10.  Cloned human phenylalanine hydroxylase gene allows prenatal diagnosis and carrier detection of classical phenylketonuria.

Authors:  S L Woo; A S Lidsky; F Güttler; T Chandra; K J Robson
Journal:  Nature       Date:  1983 Nov 10-16       Impact factor: 49.962

  10 in total
  24 in total

Review 1.  State-of-the-Art 2019 on Gene Therapy for Phenylketonuria.

Authors:  Hiu Man Grisch-Chan; Gerald Schwank; Cary O Harding; Beat Thöny
Journal:  Hum Gene Ther       Date:  2019-09-09       Impact factor: 5.695

2.  Non-physiological amino acid (NPAA) therapy targeting brain phenylalanine reduction: pilot studies in PAHENU2 mice.

Authors:  Kara R Vogel; Erland Arning; Brandi L Wasek; Teodoro Bottiglieri; K Michael Gibson
Journal:  J Inherit Metab Dis       Date:  2012-09-14       Impact factor: 4.982

3.  Differences in BTBR T+ tf/J and C57BL/6J mice on probabilistic reversal learning and stereotyped behaviors.

Authors:  Dionisio A Amodeo; Joshua H Jones; John A Sweeney; Michael E Ragozzino
Journal:  Behav Brain Res       Date:  2011-10-28       Impact factor: 3.332

4.  Autophagy induction by tetrahydrobiopterin deficiency.

Authors:  Sang Su Kwak; Jinkyu Suk; Ji Hye Choi; Seungkyung Yang; Jin Woo Kim; Seonghyang Sohn; Jae Hoon Chung; Yong Hee Hong; Dong Hwan Lee; Jeong Keun Ahn; Hyesun Min; Ya-Min Fu; Gary G Meadows; Cheol O Joe
Journal:  Autophagy       Date:  2011-11-01       Impact factor: 16.016

5.  Cerebral protein synthesis in a genetic mouse model of phenylketonuria.

Authors:  C B Smith; J Kang
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

6.  High dose sapropterin dihydrochloride therapy improves monoamine neurotransmitter turnover in murine phenylketonuria (PKU).

Authors:  Shelley R Winn; Tanja Scherer; Beat Thöny; Cary O Harding
Journal:  Mol Genet Metab       Date:  2015-11-26       Impact factor: 4.797

7.  Predictably irrational: assaying cognitive inflexibility in mouse models of schizophrenia.

Authors:  Jonathan L Brigman; Carolyn Graybeal; Andrew Holmes
Journal:  Front Neurosci       Date:  2010-05-15       Impact factor: 4.677

8.  Regionally selective decreases in cerebral glucose metabolism in a mouse model of phenylketonuria.

Authors:  M Qin; C Beebe Smith
Journal:  J Inherit Metab Dis       Date:  2007-04-24       Impact factor: 4.982

Review 9.  Progress toward cell-directed therapy for phenylketonuria.

Authors:  Co Harding
Journal:  Clin Genet       Date:  2008-05-21       Impact factor: 4.438

10.  Blood phenylalanine reduction corrects CNS dopamine and serotonin deficiencies and partially improves behavioral performance in adult phenylketonuric mice.

Authors:  Shelley R Winn; Tanja Scherer; Beat Thöny; Ming Ying; Aurora Martinez; Sydney Weber; Jacob Raber; Cary O Harding
Journal:  Mol Genet Metab       Date:  2017-10-19       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.